References
References
1. Randle P, Garland P, Hales C, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789.
2. Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care 2007;30:3131-3140.
3. McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis 2011;12:333-340.
4. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007;92:399-404.
5. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-1132.
6. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014;371:1131-1141.
7. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001;86:5755-5761.
8. Boesch C. Musculoskeletal Spectroscopy. J Magn Reson Imaging 2007;25:321-338.
9. Boesch C, Machann J, Vermathen P, Schick F. Role of proton MR for the study of muscle lipid metabolism. NMR Biomed 2006;19:968-988.
10. Heymsfield SB, Hu HH, Shen W, Carmichael O. Emerging Technologies and their Applications in Lipid Compartment Measurement. Trends Endocrinol Metab 2015;26:688-698.
11. Machann J, Horstmann A, Born M, Hesse S, Hirsch FW. Diagnostic imaging in obesity. Best Pract Res Clin Endocrinol Metab 2013;27:261-277.
12. Hu HH, Kan HE. Quantitative proton MR techniques for measuring fat. NMR Biomed 2013;26:1609-1629.
13. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34:729-749.
14. Han W, Chuang KH, Chang YT, Olivo M, Velan SS, Bhakoo K, Townsend D, Radda GK. Imaging metabolic syndrome. EMBO Mol Med 2010;2:196-210.
15. Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: Two lipid compartments in muscle tissue. Magn Reson Med 1993;29:158-167.
16. Boesch C, Slotboom H, Hoppeler H, Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 1997;37:484-493.
17. Stein, D. T., Szczepaniak, L. S., Dobbins, R., Malloy, C. R., and McGarry, J. D. Skeletal muscle triglyceride stores are increased in insulin resistance [abstract]. Diabetes 1997;46-Suppl1:23A.
18. Krssak M, Petersen KF, Dresner A, DiPietro L, Vogel SM, Rothman DL, Shulman GI, Roden M. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-116.
19. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999;48:1113-1119.
20. Pola A, Sadananthan SA, Yaligar J, Nagarajan V, Han W, Kuchel PW, Velan SS. Skeletal muscle lipid metabolism studied by advanced magnetic resonance spectroscopy. Prog NMR Spectroscopy 2012;65:66-76.
21. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, Claussen C, Jacob S, Schick F, Haring HU, Stumvoll M. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1785-1791.
22. Decombaz J, Schmitt B, Ith M, Decarli B, Diem P, Kreis R, Hoppeler H, Boesch C. Post-exercise fat intake repletes intramyocellular lipids, but no faster in trained than in sedentary subjects. Am J Physiol 2001;281:R760-R769.
23. Bucher J, Kruesi M, Zueger T, Ith M, Stettler C, Diem P, Boesch C, Kreis R, Christ E. The effect of a single bout of a 2h aerobic exercise on ectopic lipids in skeletal muscle, liver and the myocardium. Diabetologia 2014;57:1001-1005.
24. Bizino MB, Hammer S, Lamb HJ. Metabolic imaging of the human heart: clinical application of magnetic resonance spectroscopy. Heart 2014;100:881-890.
25. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007;116:1170-1175.
26. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011;332:1519-1523.
27. Amati F. Revisiting the diacylglycerol-induced insulin resistance hypothesis. Obes Rev 2012;13-Suppl2:40-50.
28. Bosma M, Kersten S, Hesselink MK, Schrauwen P. Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity. Prog Lipid Res 2012;51:36-49.
29. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 2012;148:852-871.
30. Furuyama JK, Nagarajan R, Roberts CK, Lee CC, Hahn TJ, Thomas MA. A pilot validation of multi-echo based echo-planar correlated spectroscopic imaging in human calf muscles. NMR Biomed 2014;27:1176-1183.
31. Thomas MA, Lipnick S, Velan SS, Liu X, Banakar S, Binesh N, Ramadan S, Ambrosio A, Raylman RR, Sayre J, DeBruhl N, Bassett L. Investigation of breast cancer using two-dimensional MRS. NMR Biomed 2009;22:77-91.
32. He J, Goodpaster BH, Kelley DE. Effects of weight loss and physical activity on muscle lipid content and droplet size. Obes Res 2004;12:761-769.
33. Brandejsky V, Kreis R, Boesch C. Restricted or severely hindered diffusion of intramyocellular lipids in human skeletal muscle shown by in vivo proton MR spectroscopy. Magn Reson Med 2012;67:310-316.
34. Cao P, Fan SJ, Wang AM, Xie VB, Qiao Z, Brittenham GM, Wu EX. Diffusion magnetic resonance monitors intramyocellular lipid droplet size in vivo. Magn Reson Med 2014;73:59-69.
35. Kreis R, Jung B, Rotman S, Slotboom J, Boesch C. Non-invasive observation of acetyl-group buffering by 1H-MR spectroscopy in exercising human muscle. NMR Biomed 1999;12:471-476.
36. Lindeboom L, Nabuurs CI, Hoeks J, Brouwers B, Phielix E, Kooi ME, Hesselink MK, Wildberger JE, Stevens RD, Koves T, Muoio DM, Schrauwen P, Schrauwen-Hinderling VB. Long-echo time MR spectroscopy for skeletal muscle acetylcarnitine detection. J Clin Invest 2014;124:4915-4925.
37. Delikatny EJ, Chawla S, Leung DJ, Poptani H. MR-visible lipids and the tumor microenvironment. NMR Biomed 2011;24:592-611.
38. Arias-Mendoza F, Payne GS, Zakian K, Stubbs M, O'Connor OA, Mojahed H, Smith MR, Schwarz AJ, Shukla-Dave A, Howe F, Poptani H, Lee SC, Pettengel R, Schuster SJ, Cunningham D, Heerschap A, Glickson JD, Griffiths JR, Koutcher JA, Leach MO, Brown TR. Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma. Acad Radiol 2013;20:1122-1129.
39. Podo F. Tumour phospholipid metabolism. NMR Biomed 1999;12:413-439.
40. Podo F, Canevari S, Canese R, Pisanu ME, Ricci A, Iorio E. MR evaluation of response to targeted treatment in cancer cells. NMR Biomed 2011;24:648-672.